B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas

Human Immunology

Volumn 75, Issue 12, 2014, Pages 1203-1209

  Wang, Xin ^a   Wang, Tingting ^a   Xu, Man ^a   Xiao, Ling ^a   Luo, Yi ^a   Huang, Wenlian ^a   Zhang, Yan ^a   Geng, Weipu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

B7 H4; Cell proliferation; Cervical carcinoma; Cytokine; T lymphocyte

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; KI 67 ANTIGEN; RECOMBINANT PROTEIN; VTCN1 PROTEIN, HUMAN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR MICROENVIRONMENT; UTERINE CERVIX CARCINOMA; BIOSYNTHESIS; CD4 CD8 RATIO; DRUG EFFECTS; G2 PHASE CELL CYCLE CHECKPOINT; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; SECRETION (PROCESS); TUMOR ASSOCIATED LEUKOCYTE; UTERINE CERVIX; UTERINE CERVIX TUMOR;

ADULT; AGED; APOPTOSIS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CERVIX UTERI; CYTOKINES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; KI-67 ANTIGEN; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MICROENVIRONMENT; UTERINE CERVICAL NEOPLASMS; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84927567343     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.10.002     Document Type: Article

References (19)

1. Shang-Ying H., Rong-Shou Z., Fang-Hui Z., Si-Wei Z., Wan-Qing C., You-Lin Q. Trend analysis of cervical cancer incidence and mortality rates in Chinese women during 1989-2008. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2014, 36(2):119-125.
2. Wu Y.Y., Liang M.R., Li L.Y., Zeng S.Y. Analysis of 4223 hospitalized patients with cervical cancer during 1990-2007. Zhonghua Fu Chan Ke Za Zhi 2008, 43(6):433-436.
3. Jayshree R.S., Sreenivas A., Tessy M., Krishna S. Cell intrinsic & extrinsic factors in cervical carcinogenesis. Indian J Med Res 2009, 130(3):286-295.
4. Caigan Du., Wang Yuzhou. The immunoregulatory mechanisms of carcinoma for its survival and development. J Exp Clin Cancer Res 2011, 30(1):12.
5. Zou W., Chen L. Inhibitory B7-family molecules in the tumor microenvironment. Nat Rev Immunol 2008, 8(6):467-477.
6. Salceda S.1, Tang T., Kmet M., Munteanu A., Ghosh M., Macina R., et al. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res 2005, 306(1):128-141.
7. Arigami T., Uenosono Y., Ishigami S., Hagihara T., Haraguchi N., Natsugoe S. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer. World J Surg 2011, 35(9):2051-2057.
8. Chen L.J., Sun J., Wu H.Y., Zhou S.M., Tan Y., Tan M., et al. B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol Immunother 2011, 60(7):1047-1055.
9. Galazka K., Opławski M., Windorbska W., Skret-Magierlo J., Koper K., Basta P., et al. The immunohistochemical analysis of antigens such as RCAS1 and B7H4 in the cervical cancer nest and within the fibroblasts and macrophages infiltrating the cancer microenvironment. Am J Reprod Immunol 2012, 68(1):85-93.
10. Liu W., Shibata K., Koya Y., Kajiyama H., Senga T., Yamashita M., et al. B7-H4 overexpression correlates with a poor prognosis for cervical cancer patients. Mol Clin Oncol 2014, 2(2):219-225.
11. Jordanova E.S., Gorter A., Ayachi O., Skret-Magierlo J., Koper K., Basta P., et al. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients. Clin Cancer Res 2008, 14(7):2028-2035.
12. Bedoya A.M., Jaramillo R., Baena A., Castaño J., Olaya N., Zea A.H., et al. Location and density of immune cells in precursor lesions and cervical cancer. Cancer Microenviron 2013, 6(1):69-77.
13. Sun Y., Wang Y., Zhao J., Gu M., Giscombe R., Lefvert A.K., et al. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 2006, 53(2):143-151.
14. Arigami T., Uenosono Y., Hirata M., Hagihara T., Yanagita S., Ishigami S., et al. Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis. J Surg Oncol 2010, 102(7):748-752.
15. Sica G.L., Choi I.H., Zhu G., Tamada K., Wang S.D., Tamura H., et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003, 18(6):849-861.
16. Wang X., Hao J., Metzger D.L., Ao Z., Chen L., Ou D., et al. B7-H4 treatment of T cells inhibits ERK, JNK, p38, and AKT activation. PLoS ONE 2012, 7(1):e28232.
17. Kristensen N.N., Schmidt E.G., Rasmussen S., Balk-Møller E., Claesson M.H. B7-H4-Ig treatment of normal mice changes lymphocyte homeostasis and increases the potential of regulatory T cells. Immunopharmacol Immunotoxicol 2013, 35(4):505-513.
18. Du C., Wang Y. The immunoregulatory mechanisms of carcinoma for its survival and development. J Exp Clin Cancer Res 2011, 30:12.
19. Podojil J.R., Liu L.N., Marshall S.A., Chiang M.Y., Goings G.E., Chen L., et al. B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms. J Autoimmun 2013, 44:71-81.